3/
-The vaccines⬇️⬇️the risk of infection, but are not designed for sterilizing immunity. We knew this from the original clinical trials well before Delta emerged.
-Vaccines are phenomenal in preventing severe illness.
-Much more complex than "breakthrough infections" = boost.
4/
-Want to really have the largest & most meaningful impact? Then focus on #COVID19 1st doses in the unvaccinated (locally & globally).
-Billions remain unvaccinated in low income countries. Ugh.
5/
-Unclear risk of myocarditis after dose 3 in those at risk (e.g. men under 30). Would like to see more robust safety data here.
-3rd doses for Healthcare workers? For some. There are many men under 30. See point above. Hard to make 'blanket policy' when some have a ? risk.
6/ The World Health Organization has called for a moratorium on wide-scale booster programs until 2022 given the huge global inequities.
Focused (rather than blanket) 3rd dose programs can still align with global goals.
2. We will all be exposed at some point, maybe not today or this month, but in the next year or two
3. Must continue to⬆️the # of people with antibodies (from vaccination) prior to exposure👇
4. The pandemic is not over, even in countries with +++ vaccine access. Mitigation efforts are still needed to protect the vulnerable & unvaccinated (eg ineligible, those with barriers, etc) & to prevent overwhelming the healthcare system.
(The pandemic will end, just not yet)👇
5. We may need boosters at some point. Some (e.g. immunocompromised, etc) need these now. But we *ALL* don't need these now & should be supporting global vaccine efforts (COVAX).
6. Why not get a booster tailored to the "variant du jour" later on, when you actually need one?👇
People need to know the benefits, risks, alternatives, & context when making a medical decision.
NACI describes a greater risk of myocarditis with Moderna vs Pfizer, typically in younger male cohorts. Most are mild & recover quickly.👇
3/ More info from the links above.
"The dose 2 reporting rates for all ages/genders combined were 28.2 and 8.7 per million doses administered for the Moderna vaccine and the Pfizer-BioNTech vaccine, respectively."
1. ~80% of eligible Canadians have received a 1st dose of a #COVID19 vaccine & 2nd doses coming in fast. Nice!
2. This still leaves millions unvaccinated.
3. Delta (& all COVID) is +++ contagious, so no surprises when non-vax people get infected as measures lift (eg Europe).
👇
4. While #COVID19 vaccines work extraordinarily well, there are enough unvaccinated folks who could get sick & require medical care.
5. Even if we see lower overall COVID-related healthcare usage due to significant vaccine uptake, we can't ignore pressure on healthcare system.👇
6. Think about healthcare capacity in Canada. Ontario had to essentially shut down to avoid overwhelming the healthcare system with ~600 patients admitted to ICUs with COVID-related illness. We ended up with 920.
7. This is in a province of ~14.5 million. That's a problem.
In an era where good news is in short supply, this analysis from Public Health England suggests that both Pfizer & AstraZeneca are highly effective against hospitalization with the Delta variant (after 2 doses):
The takeaways are pretty clear- we need to vaccinate quickly with smart 1&2 dose strategy focusing on vulnerable individuals & communities.
Unvaccinated & undervaccinated pockets (barriers to care, choice, etc) will be vulnerable and see spikes.
But polls show most🇨🇦to be vaxed
We are doing really well in much of Canada with the vaccine rollout, so if we play it smart with 1st and 2nd dose strategies, and continue vaccinating at a rapid pace we can avoid significant impact of this variant.